Portfolio company
Neos Ocular, Inc
United States
Raised
Undisclosed
Latest stage
Growth
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
This company develops laser-based technology to treat presbyopia for patients needing reading glasses.
SourceFunding history · 1
Similar companies
Neos Ocular, Inc
Neos Ocular develops laser-based medical devices to treat presbyopia for patients needing vision correction without reading glasses.
Orasis Pharmaceuticals
This company develops prescription eye drops for adults with age-related blurry near vision.
Tenpoint Therapeutics
This biotechnology company develops pharmaceutical treatments and engineered cell-based therapies to restore vision for patients with age-related eye conditions like presbyopia and cataracts.
Maculaser
The company develops temperature-controlled laser therapy devices for ophthalmologists to treat retinal disorders such as age-related macular degeneration and diabetic macular oedema.
ViaLase
This company develops femtosecond laser systems for treating glaucoma, providing non-invasive surgical tools to eye care professionals and healthcare providers.
IXI
This company develops autofocus glasses using real-time eye-tracking and dynamic lens technology for consumers with vision correction needs.
Norlase
This company develops portable ophthalmic laser systems for retinal and glaucoma care, serving ophthalmologists and medical clinics worldwide.
Myoptechs
This company develops contact lenses and spectacles designed to slow myopia progression in children.
